PubRank

P Barland

Author PubWeight™ 32.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med 1989 1.43
2 Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol 1979 1.39
3 Structure and function of the synovial membrane. Bull Rheum Dis 1966 1.29
4 Localization of hyaluronic acid in synovial cells by radioautography. J Cell Biol 1968 1.26
5 The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am J Med 1978 1.01
6 Articular complications of meningococcal meningitis. An immune complex disorder. Arch Intern Med 1980 1.01
7 The isolation of the membrane of the toad bladder epithelial cell. J Cell Biol 1966 1.00
8 Immunofluorescent studies of human articular cartilage. Ann Rheum Dis 1966 0.99
9 Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med 1982 0.96
10 Growth and morphological transformations of Helicobacter pylori in broth media. J Clin Microbiol 1997 0.95
11 Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum 2001 0.93
12 Studies of surface membranes of two mouse fibroblast cell lines. Biochim Biophys Acta 1972 0.89
13 Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity. J Rheumatol 1999 0.89
14 A new rapid method for the isolation of surface membranes from tissue culture cells. J Cell Biol 1970 0.89
15 Interactions of extractable nuclear antigen (ENA) and double stranded DNA. Arthritis Rheum 1974 0.88
16 The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol 1986 0.87
17 Clinical significance of immune deposits in the skin in SLE. Arthritis Rheum 1977 0.86
18 Possible relationships between an infectious agent and the immune reactions of rheumatoid synovitis. Am J Med 1973 0.86
19 Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol 1997 0.85
20 Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ involvement. J Rheumatol 1980 0.85
21 Fibromyalgia syndrome and serotonin. Clin Exp Rheumatol 2001 0.84
22 The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study. Am J Med 1981 0.84
23 Sjögren's syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis. J Rheumatol 1987 0.84
24 Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum 2000 0.84
25 Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients. Arthritis Rheum 1981 0.83
26 Antibodies to dAT detected by membrane filtration. Arthritis Rheum 1976 0.82
27 Chronic gonococcal arthritis. J Rheumatol 1989 0.81
28 Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum 1980 0.81
29 Sensorineural hearing loss in conjunction with aortic insufficiency in systemic lupus erythematosus. Scand J Rheumatol 2001 0.79
30 Psychologically distinguishable groups of rheumatoid arthritis patients: a controlled, single blind study. Psychosom Med 1982 0.78
31 Acquired antithrombin III deficiency and systemic lupus erythematosus. Ann Rheum Dis 1981 0.78
32 Soluble interleukin-2 receptor levels in lupus nephritis. Clin Nephrol 1992 0.78
33 Combined autoimmune disease in a patient with AIDS. Clin Rheumatol 2002 0.78
34 The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus. Arthritis Rheum 1985 0.77
35 The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci 1977 0.77
36 The immunoglobulin class of anti-DNA antibodies: detection by a fluorometric immunoassay: clinical and pathological correlations in SLE. J Rheumatol 1978 0.76
37 Therapeutic intensive plasmapheresis. Semin Hematol 1981 0.75
38 Antiperinuclear factor and antikeratin antibody in the diagnosis of rheumatoid arthritis: comment on the article by Kim and Weisman. Arthritis Rheum 2000 0.75
39 The co-occurrence of acute rheumatic fever and AIDS. J Rheumatol 1997 0.75
40 Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion. Am J Clin Pathol 1977 0.75
41 Vasculitis; associated with renal oncocytoma. N Y State J Med 1981 0.75
42 Erosive arthritis with dermatomyositis without elevated anti-Jo-1 antibodies and not associated with pain. J Rheumatol 1993 0.75
43 Leukocytoclastic vasculitis in an intravenous heroin abuser. N Y State J Med 1983 0.75
44 Amtiperinuclear factor and antikeratin antibody: diagnostic use in a clinical laboratory setting. J Rheumatol 2000 0.75
45 Diagnosis of lupus nephritis by skin immunofluorescence, in the absence of extrarenal manifestations of systemic lupus erythematosus. Am J Med 1977 0.75
46 The use of chemotherapeutic agents in the treatment of non-neoplastic diseases. J Chronic Dis 1971 0.75
47 Laboratory criteria for a diagnosis of systemic lupus erythematosus. JAMA 1979 0.75
48 Triad of glomerulonephritis, antinuclear antibodies, and positive skin immunofluorescence. Variant of systemic lupus erythematosus. Am J Med 1983 0.75
49 Negative staining with osmium tetroxide vapour. Nature 1966 0.75
50 Reactivation of inactive systemic lupus erythematosus. Scand J Rheumatol 1996 0.75
51 Cytotoxic factors specific for endothelial cells. Progressive systemic sclerosis without cutaneous involvement. N Y State J Med 1981 0.75
52 The 1978 annual meeting of the American Rheumatism Association. Bull Rheum Dis 1979 0.75
53 Basement membrane antibody with skin bullae. N Y State J Med 1976 0.75